on
3rd International Conference on Pharmaceutical Regulatory Affairs
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, USA
Home ABOUT OPEN ACCESS CONFERENCES JOURNALS FAQs BLOG CONTACT
Regulatory Affairs-2013
Home
Gallery
Regulatory Affairs-2013 Report

3rd International Conference on Pharmaceutical Regulatory Affairs was held during October 21-23 2013, at San Francisco-CA, USA with a theme “Embracing Recent Strategies in Global Regulatory Affairs” brought together the International blend of people from regulatory affairs industry making it the largest endeavour from OMICS Group. All the papers presented at this conference were published in special issue of Pharmaceutical Regulatory Affairs: Open Access.

Regulatory Affairs-2013 opened up new vistas and fostered collaborations in the industry and academia.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

Mohammed R Khan, Synergex Consulting, Canada
Steve Jwanouskos, OptiMedica, USA
Chitra Edwin, Cleveland HeartLab, Inc., USA
Rama K Pidaparti, Wipro Technologies, USA

OMICS Group has taken the privilege of felicitating Regulatory Affairs -2013 Organizing Committee, Keynote Speakers and business delegates who supported for the success of this event.

OMICS Group, on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance in the field of pharma regulatory affairs and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavours. Our warm gratitude to our sponsors, exhibitors & media partners for associating with the conference.

Following on the heels of this successful event we are excited to announce 4th International Conference on Pharmaceutical Regulatory Affairs to be held during September 08-10, 2014 at Raleigh, USA with a theme Key Implications in Regulatory Environment” and wish that with your overwhelming support for Regulatory Affairs -2013 will become an outstanding event.



Expert Presentations
Mohammed R Khan

Synergex Consulting

Canada
Steve Jwanouskos

OptiMedica

USA
Chitra Edwin

Cleveland HeartLab, Inc.

USA
Rama K Pidaparti

Wipro Technologies

USA
Garikapati Pavan Kumar

Wipro Technologies

India
Linda Yang

KleanGen, LLC.

USA
Mamoona F Naqvi

Gulf Pharmaceutical Industries ├óÔé¼ÔÇ£ Julphar

UAE
Kerry Diaz

Bio-K Plus International Inc.

Canada
Allan Wilson

Information Mediary Corporation

Canada
William Lee

Cato Research

USA
Gint Silins

Cullens Patent and Trade Mark Attorneys

Australia
Karolina Bate

Cyton Biosciences Limited

United Kingdom
Donald Kruppa

Azaya Therapeutics, Inc.

USA
Elvi Metsaranta

Crown CRO Oy

Finland
John L. Miller

John Miller Consulting (Aust) Pty. Ltd.

Australia
Conference Secretariat: Regulatory Affairs-2013, Conference Series Conferences
5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
Tel: +1-650-268-9744, Fax: +1-650-618-1414
Toll free: 1-800-216-6499(USA & Canada),
1-800-651-097(Australia), 0805-080048(Europe)
Operated by: Editors - Pharmaceutical Regulatory Affairs: Open Access, Journal of Bioanalysis & Biomedicine and Advances in Pharmacoepidemiology & Drug Safety
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2008-2012 Conference Series - All rights reserved